Singapore: Novartis Foundation for Sustainable Development (NFSD) has launched a new leprosy strategy focused on interru...
Singapore: Pressure BioSciences has entered into distribution agreements with three companies having combined sales cove...
Singapore: As per a recent report published in the Shanghai Securities News, China's leading price regulator will crack ...
China has cracked down on high prices and corruption in the healthcare sector. Nonetheless, the revenue growth of publ...
Singapore: China vaccine firm, Sinovac Biotech, is selected by Beijing Health Bureau as the sole supplier of inactivated...
Singapore: Logistics firm, Marken, is awarded the Best Life Science Logistics Service Provider at BioPharma Asia Industr...
Singapore: China Kanghui Holdings, a leading domestic developer, manufacturer and marketer of orthopedic implants in Chi...
Singapore: 3SBio, China based biotechnology company, has signed license agreement with JenKem Technology to develop, man...
Singapore: Biostar Pharmaceuticals, a China-based manufacturer and marketer of pharmaceutical and health supplement prod...
Singapore: Dehaier Medical Systems, an emerging leader in the development, assembly, marketing and sale of medical devic...
‎Singapore: Sinovac Biotech, a leading provider of biopharmaceutical products in China, has touched sales of $10.1...
China-based start-up company Shanghai BravoBio is dedicated to developing new types of human vaccines to fight against e...
In the 1980s, a lot of people in China suffered due to the outbreak of hepatitis A. There was no effective method to con...
Singapore: A recent analysis conducted jointly by McKinsey & Co and the China Pharmaceutical Association, the countr...
Singapore: GlaxoSmithKline, the British drug maker that is facing accusations of bribery and corruption in China seems t...
Singapore: Amerigen Pharmaceuticals's Chinese subsidiary, Suzhou Amerigen Pharmaceuticals, entered into a marketing and ...
Singapore: The newly revised policy on Good Supply Practice for Pharma Products (GSP) was recently adopted at the execu...
Singapore: Non-small cell lung cancer (NSCLC) therapeutics market value in the Asia-Pacific (APAC) region, Australia, Ch...
